-
Chlamydia trachomatis induces low-frequency, sustained CD4 T cell responses in most women, predominantly targeting chlamydial protease-like activity factor, CPAF J. Infect. Dis. (IF 5.0) Pub Date : 2024-09-09 Yanli Li, Joanna A Warren, Taylor B Poston, Genevieve Clutton, Fiona R Shaw, Shayla Z Conrad, Yinyan Xu, Xiaojing Zheng, Kacy S Yount, Catherine M O’Connell, Harold C Wiesenfeld, Toni Darville, Nilu Goonetilleke
Background Chlamydia trachomatis (CT) is a globally prevalent sexually transmitted infection (STI) that can result in pelvic inflammatory disease, ectopic pregnancy and infertility in women. Currently, there is no prophylactic vaccine. Methods This study examined T cell immunity in a cohort of women recently infected with CT. Participants were screened against peptides spanning 33 of 894 possible CT
-
Role of HLA-B*58:01-restricted CD8+ T cells in HIV-1 subtype AE infection J. Infect. Dis. (IF 5.0) Pub Date : 2024-09-09 Hung The Nguyen, Takayuki Chikata, Yu Zhang, Giang Van Tran, Hiroyuki Gatanaga, Shinichi Oka, Masafumi Takiguchi
HLA-B*58:01 and HLA-B*57 are protective alleles against HIV-1 subtype B or C infection whereas these HLA alleles have not been reported as protective in HIV-1 subtype AE infection. Although HLA-B*58:01-restricted and HLA-B*57-restricted HIV-1-specific CD8+ T cells have been thoroughly analyzed in subtype B or C infection, they have only been partially analyzed in subtype AE infection. We identified
-
A Longitudinal Analysis of Memory Immune Responses in Convalescent Crimean-Congo Hemorrhagic Fever Survivors in Uganda J. Infect. Dis. (IF 5.0) Pub Date : 2024-09-09 Courtney A Cohen, Stephen Balinandi, Ana I Kuehne, Michelle L Rock, Luke G Bonagofski, Keersten M Ricks, Ian Davis, Dafna Abelson, Spencer W Stonier, Matthew Odongo, Zachary A Bornholdt, Larry Zeitlin, Crystal Moyer, Stephen Cose, John M Dye, Julius J Lutwama, Andrew S Herbert
Evaluating the adaptive immune responses to natural infection with Crimean-Congo hemorrhagic fever (CCHF) virus (CCHFV) in human survivors is critical to the development of medical countermeasures. However, the correlates of protection are unknown. As the most prevalent tick-borne human hemorrhagic fever virus with case fatality rates of 5%–30% and worldwide distribution, there is an urgent need to
-
Vaginal Bacteria and Proinflammatory Host Immune Mediators as Biomarkers of Human Immunodeficiency Virus Acquisition Risk Among African Women J. Infect. Dis. (IF 5.0) Pub Date : 2024-09-09 Sujatha Srinivasan, Barbra A Richardson, Jacqueline M Wallis, Tina L Fiedler, Susan M Strenk, Noah G Hoffman, Sean Proll, Z Mike Chirenje, Edward W Livant, David N Fredricks, Sharon L Hillier, Jeanne M Marrazzo
Background Few investigations have assessed contributions of both vaginal bacteria and proinflammatory immune mediators to human immunodeficiency virus (HIV) acquisition risk in a prospective cohort. Methods We conducted a nested case-control study of African women who participated in a randomized placebo-controlled trial of daily oral versus vaginal tenofovir-based preexposure prophylaxis for HIV
-
Shigella and ETEC have replaced rotavirus as main causes of childhood diarrhea in Rwanda after ten years of rotavirus vaccination J. Infect. Dis. (IF 5.0) Pub Date : 2024-09-09 Jean Bosco Munyemana, Jean Claude Kabayiza, Staffan Nilsson, Maria E Andersson, Magnus Lindh
The causes of diarrhea after ten years of rotavirus vaccination in Rwanda were investigated in 496 children with and 298 without diarrhea using a real-time PCR. Rotavirus was detected in 11% of children with diarrhea (OR 2.48, P=0.002). Comparison of population attributable fractions (PAF) show that Shigella (PAF=11%) and ETEC-eltB (PAF=12%) have replaced rotavirus as the main causative agents. The
-
In-depth Analysis of the HIV Reservoir Confirms Effectiveness and Safety of Dolutegravir/Lamivudine in a Phase 4 Randomized Controlled Switch Trial (RUMBA) J. Infect. Dis. (IF 5.0) Pub Date : 2024-09-04 Marie-Angélique De Scheerder, Sophie Degroote, Mareva Delporte, Maja Kiselinova, Wim Trypsteen, Lara Vincke, Evelien De Smet, Bram Van Den Eeckhout, Loïc Schrooyen, Maxime Verschoore, Camilla Muccini, Sophie Vanherrewege, Els Caluwe, Stefanie De Buyser, Sarah Gerlo, Evy Blomme, Linos Vandekerckhove
Background Reducing the number of active compounds for lifelong human immunodeficiency virus (HIV) treatment is of interest, especially to reduce potential long-term side effects. So far, available data assessing viral control support the robustness and safety of 2DR (2-drug regimen) antiretroviral therapy compared to 3DR. However, further in-depth investigations of the viral reservoirs are mandatory
-
Association Between SARS-CoV-2 Viral Load and COVID-19 Vaccination in 4 Phase 3 Trials J. Infect. Dis. (IF 5.0) Pub Date : 2024-09-03 Holly Janes, Leigh H Fisher, Jia Jin Kee, Lalitha Parameswaran, Paul A Goepfert, Ann R Falsey, James Ludwig, Craig A Magaret, Peter B Gilbert, James G Kublin, Nadine Rouphael, Magdalena E Sobieszczyk, Hana M El Sahly, Lindsey R Baden, Beatriz Grinsztejn, Stephen R Walsh, Glenda E Gray, Karen L Kotloff, Cynthia L Gay, Alexander L Greninger, Milagritos D Tapia, E Adrianne Hammershaimb, Frances H Priddy
Coronavirus disease 2019 (COVID-19) vaccines reduce severe disease and mortality and may lessen transmission, measured by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load (VL). Evaluating vaccine associations in VL at COVID-19 diagnosis in 4 phase 3 randomized, placebo-controlled vaccine trials, July 2020 to July 2021, VL reductions were 2.78 log10 copies/mL (95% confidence interval
-
Elevated Plasma Matrix Metalloproteinases Are Associated With Mycobacterium tuberculosis Bloodstream Infection and Mortality in Human Immunodeficiency Virus-Associated Tuberculosis. J. Infect. Dis. (IF 5.0) Pub Date : 2024-09-02 Naomi F Walker,Charlotte Schutz,Amy Ward,David Barr,Charles Opondo,Muki Shey,Paul T Elkington,Katalin A Wilkinson,Robert J Wilkinson,Graeme Meintjes
Mortality from human immunodeficiency virus (HIV)-associated tuberculosis (TB) is high, particularly among hospitalized patients. In 433 people with HIV hospitalized with symptoms of TB, we investigated plasma matrix metalloproteinases (MMP) and matrix-derived biomarkers in relation to TB diagnosis, mortality, and Mycobacterium tuberculosis (Mtb) bloodstream infection (BSI). Compared to other diagnoses
-
Revealing the unseen: next generation sequencing for early detection of drug-resistant cytomegalovirus variants upon letermovir prophylaxis failure J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-30 Klaudia Nägele, Veronika Bättig, Rainer Gosert, Carla S Walti, Spasenija Savic Prince, Jörg Halter, Roby Mathews, Claudia Stühler, Nina Khanna, Karoline Leuzinger
In allogeneic hematopoietic cell transplant (HCT)-recipients, prophylactic management strategies are essential for preventing CMV-reactivation and associated disease. We report on a 63-year-old male patient with a D-/R+ CMV-serostatus, who showed ongoing low-level CMV-replication post-HCT despite receiving letermovir prophylaxis. Sanger-sequencing failed to detect drug resistance mutations (DRM) until
-
Sustained Spread of HIV-1 CRF55_01B in Its Place of Initial Origin: Dynamics and Hotspots. J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-29 Minghui An,Chenli Zheng,Lin Chen,Hao Li,Yan Zhang,Yongxia Gan,Bin Zhao,Hui Zhang,Xiaoxu Han,Jin Zhao,Hong Shang
BACKGROUND Shenzhen, a city with a substantial mobile population, was identified as the first discovered region of HIV-1 CRF55_01B and epicenter of its severe epidemic. During the implementation of venue-based behavioral interventions and the "treat-all" policy, discerning the spread patterns and transmission hotspots of CRF55_01B is imperative. METHODS In this study, 1,450 partial pol sequences, with
-
Human papillomavirus prevalence among Australian men aged 18–35 years in 2015–2018 according to vaccination status and sexual preference J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-29 Prisha Balgovind, Eithandee Aung, Hannah Shilling, Gerald L Murray, Monica Molano, Suzanne M Garland, Christopher K Fairley, Marcus Y Chen, Jane S Hocking, Catriona Ooi, Anna McNulty, Jenny McCloskey, Kathleen McNamee, Deborah Bateson, Louise Owen, Sepehr N Tabrizi, Dorothy A Machalek
Background Australia introduced a national HPV vaccination program for girls in 2007 and boys in 2013, achieving high coverage in both populations. We assessed HPV prevalence among men who have sex with women (MSW) and men who have sex with men (MSM) aged 18–35 years and examined program effects by vaccination status. Methods Men recruited between 2015–2018 self-collected a penile or intra-anal swab
-
Galectin-9 Levels as a Potential Predictor of Intact HIV Reservoir Decay J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-29 Sergio Serrano-Villar, Akshay Gala, Peter Bacchetti, Rebecca Hoh, Clara di Germanio, Lillian B Cohn, Timothy J Henrich, Peter W Hunt, Gregory M Laird, Satish K Pillai, Steven G Deeks, Michael J Peluso
Background During antiretroviral therapy (ART), the HIV reservoir exhibits variability as cells with intact genomes decay faster than those with defective genomes, especially in the first years of therapy. The host factors influencing this decay are yet to be characterized. Methods Observational study in 74 PWH on ART, of whom 70 (94.6%) were male. We used the intact proviral DNA assay to measure
-
Impact of HLA allele-KIR partners on sexually transmitted HIV-1 infection J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-29 Carmen Serrano-Rísquez, Mohamed Omar, Norma Rallón, José Miguel Benito, Amparo Gómez-Vidal, Francisco José Márquez, Martina Alján, Antonio Rivero-Juárez, Ignacio Pérez-Valero, Antonio Rivero, Faruk Sinangil, Irma Saulle, Mara Biasin, Mario Clerici, Donald Forthal, Maria Eugenia Saéz, Antonio Caruz
HLA-I/KIR genotypes influence HIV-1 disease progression and viral load, but their role in primary infection is uncertain. Inconsistent results from previous studies suggest that the inoculum size and transmission route—parenteral vs. sexual—may influence this association. We conducted a GWAS in a population of people living with HIV-1 and HIV-1-exposed seronegative individuals exposed to the virus
-
Circulating immune complexes and G6PD deficiency predict readmissions for blackwater fever and severe anemia in children with severe malaria in Eastern Uganda J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-29 Ruth Namazzi, Kagan A Mellencamp, Robert O Opoka, Dibyadyuti Datta, Giselle Lima-Cooper, Claire Liepmann, Julian Sherman, Ana Rodriguez, Caroline Kazinga, Russell E Ware, Michael G Goings, Marcus Lacerda, Marco Abreu, Tae-Hwi Schwantes-An, Chandy C John, Andrea L Conroy
Background Recently, there has been an unexplained increase in the incidence of blackwater fever (BWF) in Eastern Uganda. In this study, we evaluate the association between immune complexes, glucose-6-phosphate dehydrogenase (G6PD) deficiency, and the occurrence and recurrence of BWF in children with severe malaria (SM). Methods Between 2014 and 2017, children aged six months to <4 years hospitalized
-
A rapid molecular detection tool for toxigenic M1UK Streptococcus pyogenes J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-29 Stephan Brouwer, Swairindhree Das, Andrew J Hayes, Olivia M Bertolla, Mark R Davies, Mark J Walker, David M Whiley, Adam D Irwin, Jacob A Tickner
Background The gradual replacement of the Streptococcus pyogenes M1global genotype by a newly emergent M1UK variant is a global public health threat warranting increased surveillance. M1UK differs from progenitor M1global genotype by 27 single nucleotide polymorphisms (SNPs) and is characterised by increased speA superantigen expression in vitro. Methods An allele-specific real-time PCR assay was developed
-
CSF Cytokines and Chemokines Involved in Cytotoxic Cell Function and Risk of Acute 14-Day Mortality in Persons with Advanced HIV and Cryptococcal Meningitis. J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-28 Elizabeth C Okafor,Liliane Mukaremera,Kathy H Hullsiek,Nicole Engen,Lillian Tugume,Kenneth Ssebambulidde,Abdu Musubire,Edwin Nuwagira,Edward Mpoza,Darlisha A Williams,Conrad Muzoora,Joshua Rhein,David B Meya,Kirsten Nielsen,David R Boulware,
BACKGROUND Despite availability of HIV treatment globally, cryptococcal meningitis continues to cause considerable morbidity and mortality. The role of the immune response in acute mortality remains unclear. METHODS To investigate the immune environment in the central nervous system, cerebrospinal fluid (CSF) from 337 Ugandans with advanced HIV and first-episode cryptococcal meningitis was collected
-
Immune Complexes in Blackwater Fever and Severe Malarial Anemia: New Insights from Old Forgotten Friends. J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-28 David Torres-Fernandez,Quique Bassat
-
Clinical application of phage immunoprecipitation sequencing to diagnose enterovirus D68 as the underlying etiology in a case of Gullain-Barré syndrome J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-28 Fang Fang Li, Alison Faber, Jessica M Caleta, David M Goldfarb, Inna Sekirov, Natalie A Prystajecky, Jocelyn A Srigley, Ram Mishaal, Agatha N Jassem
Gullain-Barré syndrome (GBS) is an acute peripheral neuropathy often preceded by respiratory or gastrointestinal infections, though molecular testing of cerebrospinal fluid (CSF) is often inconclusive. In a recent case of severe pediatric GBS in British Columbia, Canada, we detected CSF antibodies against enterovirus D (EV-D) to link GBS with prior EV-D68 respiratory infection.
-
Molecular Epidemiology of Wild Poliovirus Type 1 and Shift in the Historically Reservoir Areas of Pakistan During 2019-2022 J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-28 Yasir Arshad, Nayab Mehmood, Muhammad Masroor Alam, Adnan Khurshid, Ribqa Akhtar, Ghulam Mujtaba, Lubna Rehman, Nighat Mushtaq, Bisma Sarfraz, Rabia Hakim, Massab Umair, Muhammad Suleman Rana, Muhammad Salman, Salmaan Sharif, Sadia Sattar, Sundus Javed, Muzzamil Ahmed, Zainul Abedin Khan, Mohammed Ahmed Soghaier, Nazish Bostan
Background Pakistan is one of the two countries endemic for wild poliovirus type 1 (WPV1). Active clinical and environmental wastewater surveillance along with laboratory investigation is an integral and primary component of the polio eradication strategies. The current study is mainly focused on the virological data to understand the current epidemiology of WPV1 in Pakistan during 2019-2022. Methods
-
Transcriptomic evidence of immune modulation in subjects with chronic Trypanosoma cruzi infection J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-28 Albert Ros-Lucas, Juan Carlos Gabaldón-Figueira, Nieves Martinez-Peinado, Irene Losada-Galvan, Elizabeth Posada, Elisa Escabia, Beatriz Martín-Mur, Marta Gut, Anna Esteve-Codina, Joaquim Gascón, María-Jesús Pinazo, Julio Alonso-Padilla
Chagas disease is a neglected tropical infection that affects millions of people. This study explores transcriptomic changes in T. cruzi-infected subjects before and after treatment. Using total RNA sequencing, gene transcription was analyzed in peripheral blood mononuclear cells from asymptomatic (n=19) and symptomatic (n=8) T. cruzi-infected individuals, and non-infected controls (n=15). Differential
-
Dynamic landscape of mpox importation risks driven by heavy-tailed sexual contact networks among men who have sex with men in 2022 J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-28 Sung-mok Jung, Fuminari Miura, Hiroaki Murayama, Sebastian Funk, Jacco Wallinga, Justin Lessler, Akira Endo
Background During the 2022 global mpox outbreak, the cumulative number of countries reporting their first imported case quickly rose in the early phase, but the importation rate subsequently slowed down, leaving many countries reporting no cases by the 2022 year-end. Methods We developed a mathematical model of international dissemination of mpox infections incorporating sexual networks and global
-
Interplay between viral shedding, age, and symptoms on individual infectiousness of influenza cases in households J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-28 Chengyao Zhang, Vicky J Fang, Kwok-Hung Chan, Gabriel M Leung, Dennis K M Ip, J S Malik Peiris, Benjamin J Cowling, Tim K Tsang
Background Understanding factors affecting the infectiousness of influenza cases is crucial for disease prevention and control. Viral shedding is expected to correlate with infectiousness of cases, but it is strongly associated with age and the presence of symptoms. Methods To elucidate this complex interplay, we analyze with an individual-based household transmission model a detailed household transmission
-
CDC-Funded HIV Testing Services Outcomes in Ending the HIV Epidemic in the U.S. (EHE) and Non-EHE Jurisdictions, 2021 J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-28 Deesha Patel, Mesfin S Mulatu, Guoshen Wang, Alicia C May, Andrea Moore, Shubha Rao
Background Ending the HIV Epidemic in the U.S. (EHE) aims to end the HIV epidemic by focusing on 57 jurisdictions most impacted by HIV. Methods Using 2021 data from the National HIV Prevention Program Monitoring and Evaluation system, we calculated distributions of CDC-funded HIV tests and HIV testing services outcomes in EHE and non-EHE jurisdictions. We conducted chi-square tests and robust Poisson
-
-
Trends and Patterns of HIV Transmitted Drug Resistance in China From 2018 to 2023. J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-27 Jingrong Ye,Yuan Dong,Yun Lan,Jing Chen,Ying Zhou,Jinjin Liu,Dan Yuan,Xinli Lu,Weigui Guo,Minna Zheng,Hong Yang,Xiao Song,Cong Liu,Quanhua Zhou,Chenli Zheng,Qi Guo,Xiaohui Yang,Lincai Zhang,Zhangwen Ge,Lifeng Liu,Fengting Yu,Yang Han,Huihuang Huang,Mingqiang Hao,Yuhua Ruan,Jianjun Wu,Jianjun Li,Qiang Chen,Zhen Ning,Xuemei Ling,Chang Zhou,Xuangu Liu,Jianyun Bai,Ya Gao,Xue Tong,Kangping Zhou,Fanghua
BACKGROUND National treatment guidelines of China evolving necessitates population-level surveillance of transmitted drug resistance (TDR) to inform or update HIV treatment strategies. METHODS We analyzed the demographic, clinical, and virologic data obtained from people with HIV (PWH) residing in 31 provinces of China who were newly diagnosed between 2018 and 2023. Evidence of TDR was defined by the
-
Sex Workers and the Mpox Response in Africa J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-27 Yusuff Adebayo Adebisi, Somtochukwu Marycynthia Ezema, Obasanjo Bolarinwa, Archibong Edem Bassey, Isaac Olushola Ogunkola
The ongoing Mpox (Monkeypox) outbreak in Africa, now classified as a Public Health Emergency of International Concern (PHEIC) by the World Health Organization (WHO), presents a severe challenge, particularly for vulnerable populations like sex workers. Despite the endemic presence of Mpox in Africa since the 1970s, recent developments, including the emergence of a new clade Ib strain with increased
-
A Decade of Chronic Norovirus Infection Surveillance at the NIH Clinical Research Center: Clinical Characteristics, Molecular Epidemiology, and Replication J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-27 Natthawan Chaimongkol, Daniel Y Kim, Yuki Matsushima, Jessica Durkee-Shock, Karenna Barton, Courtney N Ahorrio, Gary A Fahle, Karin Bok, Allison Behrle-Yardley, Jordan A Johnson, Dennise A de Jesús-Díaz, Gabriel I Parra, Eric A Levenson, Fernando Yukio Maeda, Stanislav V Sosnovtsev, Kim Y Green
Background Noroviruses are an important viral cause of chronic diarrhea in immunocompromised individuals. Method We collected norovirus-positive stool samples (n=448) from immunocompromised patients (n=88) at the National Institutes of Health Clinical Research Center, U.S. from 2010-2022. We assessed clinical characteristics of the cohort, norovirus molecular epidemiology, and infectivity of norovirus
-
Planning and Analyzing a Low-Biomass Microbiome Study: A Data Analysis Perspective J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-27 George I Austin, Tal Korem
As investigations of low-biomass microbial communities have become more common, so too has the recognition of major challenges affecting these analyses. These challenges have been shown to compromise biological conclusions and have contributed to several controversies. Here, we review some of the most common and influential challenges in low-biomass microbiome research. We highlight key approaches
-
Genomic Epidemiology of Mycobacterium abscessus on the Island of Montréal Not Suggestive of Healthcare-associated Person-to-Person Transmission J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-27 Idowu B Olawoye, Nicholas Waglechner, Fiona McIntosh, Pierre-Marie Akochy, Nancy Cloutier, Simon Grandjean Lapierre, Bouchra Tannir, Christina Greenaway, Elias Matouk, Louise Poirier, Roger C Levesque, Brian Boyle, Caroline Quach, Hafid Soualhine, Jane Batt, Marcel A Behr, Robyn S Lee, Jennifer L Guthrie
Background Mycobacterium abscessus complex (MABC), an opportunistic nontuberculous mycobacteria (NTM), can lead to poor clinical outcomes in pulmonary infections. Conflicting data exist on person-to-person transmission of MABC within and across healthcare facilities. To investigate further, a comprehensive retrospective study across five healthcare institutions on the Island of Montréal was undertaken
-
Human infection with IsrRAPXV, a novel zoonotic bat-derived poxvirus J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-26 Yael Paran, Dan David, Nir Rudoler, Merav Ingbir, Nardeen Khoury, Ora Halutz, Ronen Ben-Ami, Asaf Berkowitz, Asaf Sol
Background Bats are recognized as the natural reservoir of several zoonotic viruses that pose a threat to public health worldwide. In our recent reports we describe the identification of a novel poxvirus, IsrRAPXV, in Egyptian fruit bats. This poxvirus is associated with high morbidity and mortality in bats. Methods Herein, we describe the identification of poxvirus in a female patient hospitalized
-
Improvement in the 95-95-95 Targets Is Accompanied by a Reduction in Both the Human Immunodeficiency Virus Transmission Rate and Incidence in China J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-26 Jingrong Ye, Yun Lan, Juan Wang, Yi Feng, Yi Lin, Ying Zhou, Jinjin Liu, Dan Yuan, Xinli Lu, Weigui Guo, Minna Zheng, Xiao Song, Quanhua Zhou, Hong Yang, Chenli Zheng, Qi Guo, Xiaohui Yang, Kai Yang, Lincai Zhang, Zhangwen Ge, Lifeng Liu, Fengting Yu, Yang Han, Huihuang Huang, Mingqiang Hao, Qiang Chen, Xuemei Ling, Yuhua Ruan, Yuan Dong, Chang Zhou, Xuangu Liu, Jianyun Bai, Xue Tong, Ya Gao, Zhengrong
Background In 2016, China has implemented the World Health Organization's “treat all” policy. We aimed to assess the impact of significant improvements in the 95-95-95 targets on population-level human immunodeficiency virus (HIV) transmission dynamics and incidence. Methods We focused on 3 steps of the HIV care continuum: diagnosed, on antiretroviral therapy, and achieving viral suppression. The molecular
-
C-C Motif Ligand 7 (CCL7) and C-C Motif Chemokine Receptor 3 (CCR3) dysregulation in patients with scrub typhus and association with mortality J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-23 Thor Ueland, Elisabeth Astrup, Kari Otterdal, Tove Lekva, Jeshina Janardhanan, Annika E Michelsen, Pål Aukrust, George M Varghese, Jan K Damås
Background Scrub typhus, caused by Orientia tsutsugamushi involves infiltration of a mixture of perivascular lymphocytes and macrophages into affected organs. We investigated if this is characterized by chemokine dysregulation. Methods mRNA expression of chemokines and receptors were screened in whole blood by cDNA microarray in a subgroup of patients and controls. Regulated transcripts were analyzed
-
Efficacy and safety of artemether-lumefantrine against uncomplicated falciparum malaria infection in Tanzania, 2022, a single arm clinical trial J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-23 Jessica E Laury, Kefas Mugittu, Debora C Kajeguka, Erasmus Kamugisha, Deus S Ishengoma, Celine I Mandara, Billy Ngasala, Mercy G Chiduo, Muhidin K Mahende, Jovin Kitau, Maimuna M Ahmed, Sixbert I Mkumbaye, Filbert Francis, Frank Chacky, Marian Warsame, Naomi Serbantez, Chonge Kitojo, Erik J Reaves, Dunstan R Bishanga, Marko Bajic, Bilali I Kabula, Florida Muro, Reginald A Kavishe
Background Artemether-lumefantrine (AL) is the first line anti-malarial drug for the treatment of uncomplicated malaria in Tanzania. The World Health Organization (WHO) recommends regular efficacy monitoring of anti-malarial drugs to inform case management policy decisions. This study assessed the safety and efficacy of AL for treating uncomplicated P. falciparum malaria in Tanzania in 2022. Methods
-
Respiratory Viral Infections from 2015 to 2022 in the HIVE Cohort of American Households: Incidence, illness characteristics, and seasonality J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-23 Arnold S Monto, Joshua E Foster-Tucker, Amy P Callear, Aleda M Leis, Elie-Tino Godonou, Matthew Smith, Rachel Truscon, Emileigh Johnson, Lara J Thomas, Mark S Thompson, Alicia M Fry, Brendan Flannery, Ryan E Malosh, Joshua G Petrie, Adam S Lauring, Emily T Martin
Background Viral respiratory illnesses are the most common acute illnesses experienced and generally follow a predicted pattern over time. The SARS-CoV-2 pandemic interrupted that pattern. Methods The HIVE (Household Influenza Vaccine Evaluation) study was established in 2010 to follow a cohort of Southeast Michigan households over time. Initially focused on influenza, surveillance was expanded to
-
A Correspondence on Neutrophil-Associated Proteins as Novel Biomarkers Elevated in Cerebrospinal Fluid of Patients With Neurosyphilis. J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-22 Huan Wang,Chenwei Diao
-
Efficacy and Safety of Pimodivir Combined with Standard-of-care in Hospitalized and Non-hospitalized High-risk Adolescents and Adults with Influenza A Infection J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-22 Lorant Leopold, Johan Vingerhoets, Sofie Deleu, Catherine Nalpas, Karin Weber, Ilse van Dromme, David Lowson, Bart Michiels, Wilbert van Duijnhoven
Background An unmet need exists for effective antivirals to treat patients hospitalized with influenza. The results of 2 Phase 3 studies evaluating the efficacy and safety of pimodivir in combination with investigator-chosen standard-of-care (SoC) treatment are presented. Methods Hospitalized patients (hospital study; NCT03376321) and high-risk outpatients (outpatient study; NCT03381196) with laboratory-confirmed
-
Deletion of BTB and CNC homology 1 protects against Staphylococcus aureus-induced acute lung injury J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-22 Jiaojiao Sun, Dapeng Liu, Sihao Jin, Xiaolin Li, Gang Liu, Shengpeng Li, Fan Chen, Xiaoyun Qin, Yanli Zhang, Fengjuan Jiang, Dan Chen, Qingfeng Pang, Chunxiao Hu, Yaxian Wu, Zhiqiang Wang
BTB and CNC homology 1 (BACH1) plays a crucial role in the pathogenesis of acute lung injury (ALI) caused by gram-negative bacteria. However, its exact mechanisms and roles in Staphylococcus aureus (SA)-induced ALI, a gram-positive bacterial infection, remain incompletely understood. In this study, we generated a BACH1-knockout mouse model (BACH1-/-) to investigate the role of BACH1 and its underlying
-
Residency in Long-Term Care Facilities: An Important Risk Factor for RSV Hospitalization J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-22 Angela R Branche, Ann R Falsey, Lyn Finelli, Edward E Walsh
Older age and comorbid conditions increase risk for severe RSV. Skilled nursing (SNF) and assisted living (AL) facilities represent an intersection of risk factors. In a 3-year prospective study (Rochester, NY) we compared population-based incidence of RSV-associated hospitalization for community-dwelling, SNF and AL adults ≥65 years. Median age was 76, 83 and 86 years, respectively, and dementia and
-
Disease-specific differences in pharmacokinetics of paromomycin and miltefosine between post-kala-azar dermal leishmaniasis and visceral leishmaniasis patients in eastern Africa J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-22 Wan-Yu Chu, Luka Verrest, Brima M Younis, Ahmed M Musa, Jane Mbui, Rezika Mohammed, Joseph Olobo, Koert Ritmeijer, Séverine Monnerat, Monique Wasunna, Ignace C Roseboom, Alexandra Solomos, Alwin D R Huitema, Fabiana Alves, Thomas P C Dorlo
Treatment regimens for post-kala-azar dermal leishmaniasis (PKDL) are usually extrapolated from those for visceral leishmaniasis (VL), but drug pharmacokinetics (PK) can differ due to disease-specific variations in absorption, distribution, and elimination. This study characterized PK differences in paromomycin and miltefosine between 109 PKDL and 264 VL patients from eastern Africa. VL patients showed
-
Bladder catheterization improves bacterial interference with asymptomatic Escherichia coli 83972 in an experimental porcine model of urinary tract infection. J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-20 Kristian Stærk,Karin Andersen,Jannie Søvsø Hjelmager,Louise Kruse Jensen,Benjamin Meyer Jørgensen,Jakob Møller-Jensen,Lars Lund,Thomas Emil Andersen
BACKGROUND Urinary tract infection (UTI) is a common disease with a significant risk of relapse. Deliberate bladder colonization with asymptomatic Escherichia coli is being explored as a potential strategy to fend off invading uropathogens thereby mitigating the risk symptomatic UTI. Currently, one major obstacle is the low success rates for achieving persistent bladder colonization with asymptomatic
-
Microbiome and Metabolome Restoration After Administration of Fecal Microbiota, Live-jslm (REBYOTA®) for Preventing Recurrent Clostridioides difficile Infection J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-19 Ken F Blount, Romeo Papazyan, Nicky Ferdyan, Karthik Srinivasan, Carlos Gonzalez, William D Shannon, Bryan C Fuchs
Background Microbiota-based treatments are effective in preventing recurrent Clostridioides difficile infection (rCDI). Fecal microbiota, live-jslm (REBYOTA®; RBL, previously RBX2660) was shown to prevent rCDI in a phase 3, randomized, double-blinded placebo controlled clinical trial (PUNCH™ CD3). Methods Stool samples from participants in PUNCH™ CD3 who received a single blinded dose of rectally administered
-
Ex vivo host transcriptomics during Cryptococcus neoformans, Cryptococcus gattii, and Candida albicans infection of PBMCs from South African volunteers J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-19 Ronan M Doyle, Shichina Kannambath, Alan Pittman, Rene Goliath, Vinod Kumar, Graeme Meintjes, James Milburn, Mihai G Netea, Thomas S Harrison, Joseph N Jarvis, Tihana Bicanic
Cryptococcus neoformans, Cryptococcus gattii and Candida albicans are opportunistic fungal pathogens associated with infections in immunocompromised hosts. Cryptococcal meningitis (CM) is the leading fungal cause of HIV-related deaths globally, with the majority occurring in Africa. The human immune response to C. albicans infection has been studied extensively in large genomics studies whereas cryptococcal
-
Role of serial fluorodeoxyglucose positron emission tomography-computed tomography (18FDG-PET-CT) in assessing treatment response in treatment naïve chronic pulmonary aspergillosis subjects J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-19 Inderpaul Singh Sehgal, Kajal Arora, Ritesh Agarwal, Rajender Kumar, Nivedita Rana, Sahajal Dhooria, Valliappan Muthu, Kuruswamy Thurai Prasad, Mandeep Garg, Shivaprakash M Rudramurthy, Ashutosh Nath Aggarwal, Arunaloke Chakrabarti
Background The role of 2-deoxy-2-18(F) fluoro-D-glucose (FDG) positron emission tomography (PET)-computed tomography (CT) in assessing treatment response in chronic pulmonary aspergillosis (CPA) remains to be determined. Objective To compare changes in FDG-PET/CT parameters in CPA subjects with treatment success or failure. Methods We treated consecutive treatment-naïve CPA subjects with six months
-
Bacterial Genomics for National Antimicrobial Resistance Surveillance in Cambodia J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-17 Christina Yek, Chanthap Lon, Sophana Chea, Sreyngim Lay, Meng Heng Oum, Gechlang Tang, Chansothea Lon, Andrea R Pacheco, Ian Drobish, Reagan Stuehser, Sokna Ly, Ratanak Sath, Malin Srouen, Chamrouen Bin, Chanthou Chak, Sosorphea Seang, Viso Srey, Bunna Chhor, Somary Nhem, Sivhour Chiek, Rina Dork, John P Dekker, Heng Seng, Sidonn Krang, Sovann Ly, Jessica E Manning
Background Antimicrobial resistance (AMR) surveillance in low- and middle-income countries (LMICs) often relies on poorly resourced laboratory processes. Centralized sequencing was combined with cloud-based, open-source bioinformatics solutions for national AMR surveillance in Cambodia. Methods Blood cultures growing gram-negative bacteria were collected at six Cambodian hospitals (January 2021 – October
-
T-Cell Responses to Treponema pallidum Proteins in Blood and Skin to Advance Syphilis Vaccine Design: Learning From Nature. J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-16 Juan C Salazar,Justin D Radolf
-
-
Correction to: Comparative Analysis of Ebola Virus Glycoprotein Interactions With Human and Bat Cells. J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-16
-
Characterization of Treatment Resistance and Viral Kinetics in the Setting of Single-Active Versus Dual-Active Monoclonal Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2. J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-16 Manish C Choudhary,Rinki Deo,Teresa H Evering,Kara W Chew,Mark J Giganti,Carlee Moser,Justin Ritz,James Regan,James P Flynn,Charles R Crain,David Alain Wohl,Judith S Currier,Joseph J Eron,David Margolis,Qing Zhu,Lijie Zhon,Li Ya,Alexander L Greninger,Michael D Hughes,Davey Smith,Eric S Daar,Jonathan Z Li
BACKGROUND Monoclonal antibodies (mAbs) represent a crucial antiviral strategy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, but it is unclear whether combination mAbs offer a benefit over single-active mAb treatment. Amubarvimab and romlusevimab significantly reduced the risk of hospitalizations or death in the ACTIV-2/A5401 trial. Certain SARS-CoV-2 variants are intrinsically
-
Analysis of a Large Severe Acute Respiratory Syndrome Coronavirus 2 (Alpha) Outbreak in a Catalan Prison Using Conventional and Genomic Epidemiology. J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-16 Antoni E Bordoy,Xavier Vallès,Juan Fernández-Náger,Montserrat Sánchez-Roig,Juan Fernández-Recio,Verónica Saludes,Marc Noguera-Julian,Ignacio Blanco,Elisa Martró,
Enforcing strict protocols that prevent transmission of airborne infections in prisons is challenging. We examine a large severe acute respiratory syndrome coronavirus 2 outbreak in a Catalan penitentiary center in February-April 2021, prior to vaccination deployment. The aim was to describe the evolution of the outbreak using classical and genomic epidemiology and the containment strategy applied
-
Mitochondrial Haplogroups and Weight Gain After Initiating ART in Patients With HIV. J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-16 Juan Berenguer,Inmaculada Jarrín,José M Bellón,Cristina Díez,María A Jiménez-Sousa,Juan C López,Adriana Pinto-Martínez,Santiago Moreno,María L Montes,José A Iribarren,Eva Orviz,Joaquín Portilla,Francesc Villarroya,Pere Domingo,Salvador Resino,
We studied the association of mitochondrial DNA (mtDNA) haplogroups with weight and body mass index (BMI) gain at 96 weeks in 1019 treatment-naive persons with HIV (PWH) who initiated first-line antiretroviral therapy (ART) since 2014. The mean increase in weight and BMI over the study period was 2.90 kg and 0.98 kg/m2, respectively. We found a significant adjusted association between the major UK
-
Laboratory Testing for Powassan Virus: Past, Present, and Future. J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-14 Erik H Klontz,Navid Chowdhury,John A Branda
Powassan virus is a tick-borne flavivirus that can cause severe neuroinvasive disease, with areas of endemicity in the Northeast and Midwest United States, Canada, and Russia. Diagnosis is challenging and relies on a high index of suspicion and choosing the right test based on duration of infection and the patient's immune status. This review covers laboratory testing for Powassan virus, including
-
Identification of Major Histocompatibility Complex Class II Epitopes From Lyme Autoantigen Apolipoprotein B-100 and Borrelia burgdorferi Mcp4 in Murine Lyme Arthritis. J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-14 Rebecca Danner,Lauren M Prochniak,Michaela Pereckas,Joseph R Rouse,Amanda Wahhab,Lauren G Hackner,Robert B Lochhead
BACKGROUND During infection with the Lyme arthritis (LA) pathogen Borrelia burgdorferi, T-cell responses to both host and pathogen are dysregulated, resulting in chronic infection and frequent development of autoimmunity. METHODS To assess CD4+ T-cell epitopes presented during development of LA, we used an unbiased, immunopeptidomics approach to characterize the major histocompatibility complex (MHC)
-
Insights From Omics in Lyme Disease. J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-14 Linda K Bockenstedt,Alexia A Belperron
Lyme disease is a zoonotic infection due to Ixodes tick-transmitted Borrelia burgdorferi sensu lato spirochetes and the most common vector-borne disease in the Northern Hemisphere. Despite nearly 50 years of investigation, the pathogenesis of this infection and its 2 main adverse outcomes-postinfectious Lyme arthritis and posttreatment Lyme disease syndrome-are incompletely understood. Advancement
-
Variants in the Late Cornified Envelope Gene Locus Are Associated With Elevated T-helper 17 Responses in Patients With Postinfectious Lyme Arthritis. J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-14 Dylan Ehrbar,Sheila L Arvikar,Katherine B Sulka,Geena Chiumento,Nicole L J Nelson,Sergio A Hernandez,Morgan A Williams,Franc Strle,Allen C Steere,Klemen Strle
BACKGROUND Postinfectious Lyme arthritis (LA) is associated with dysregulated immunity and autoreactive T- and B-cell responses in joints. Here we explored the role of host genetic variation in this outcome. METHODS The frequency of 253 702 single-nucleotide polymorphisms (SNPs) was determined in 147 patients with LA (87 with postinfectious LA and 60 with antibiotic-responsive LA), and for comparison
-
Lyme Disease Surveillance and Epidemiology in the United States: A Historical Perspective. J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-14 Paul Mead,Alison Hinckley,Kiersten Kugeler
In the 40 years since Steere and colleagues first described Lyme disease, the illness has increased in incidence and distribution to become the most common vector-borne disease in the United States. Public health officials have developed, implemented, and revised surveillance systems to describe and monitor the condition. Much has been learned about the epidemiology of the illness, despite practical
-
Persistent Symptoms After Lyme Disease: Clinical Characteristics, Predictors, and Classification. J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-14 M E Baarsma,Joppe W Hovius
Persistent symptoms after an infection have been described for a number of infectious diseases, including Lyme disease. Studies have confirmed a moderate but consistent increase in the prevalence of such symptoms after Lyme disease, though the risk increase varies dependent on study design and the definition of persistent symptoms. Various possible predictors have been proposed, including a dysregulation
-
Vaccination to Prevent Lyme Disease: A Movement Towards Anti-Tick Approaches. J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-14 Emily E Johnson,Thomas M Hart,Erol Fikrig
Lyme disease is caused by the spirochete, Borrelia burgdorferi, which is transmitted by Ixodes spp ticks. The rise in Lyme disease cases since its discovery in the 1970s has reinforced the need for a vaccine. A vaccine based on B burgdorferi outer surface protein A (OspA) was approved by the Food and Drug Administration (FDA) several decades ago, but was pulled from the market a few years later, reportedly
-
Comparative Evaluation of Commercial Test Kits Cleared for Use in Modified Two-Tiered Testing Algorithms for Serodiagnosis of Lyme Disease. J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-14 Elizabeth L Lewandrowski,Sarah E Turbett,Lise E Nigrovic,Erik H Klontz,John A Branda
BACKGROUND Modified 2-tiered testing (MTTT) for Lyme disease utilizes automatable, high throughput immunoassays (AHTIs) in both tiers without involving western immunoblots, offering performance and practical advantages over standard 2-tiered testing (STTT; first-tier AHTI followed by immunoglobulin M (IgM) and immunoglobulin G (IgG) western immunoblots). For MTTT, Centers for Disease Control and Prevention
-
Reconstitution of norovirus-specific T cell responses following hematopoietic stem cell transplantation in patients with inborn errors of immunity and chronic norovirus infection J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-14 Jessica Durkee-Shock, Ariella Cohen, Naseem Maghzian, Gloria Pezzella, Mariah Jensen-Wachspress, Anna Hostal, Karenna Barton, Krista Gangler, Blachy J Dávila Saldaña, Natthawan Chaimongkol, Catherine M Bollard, Stanislav V Sosnovtsev, Jeffrey Cohen, Bianca M Nagata, Derron A Alves, Rajarshi Ghosh, Bryce A Seifert, Alexandra Freeman, Corina Gonzalez, Luigi D Notarangelo, Kim Y Green, Michael D Keller
Background Chronic norovirus infection (CNI) causes significant morbidity in immunocompromised patients. No effective prevention or treatment currently exists. Methods Two patients with inborn errors of immunity, X- linked severe combined immunodeficiency (X-SCID) and DOCK8 deficiency, were followed longitudinally for clinical course, immune reconstitution, norovirus-specific T cell (NST) response
-
Disparate SARS-CoV-2 infection outcomes abound, but what makes SARS-CoV-2 bound for rebound? J. Infect. Dis. (IF 5.0) Pub Date : 2024-08-13 Timothy P Sheahan